跳至主要内容
临床试验/NCT00128427
NCT00128427已完成3 期

Treatment and Prevention of Pericarditis With Colchicine. A Multicenter Double Blind Randomized Trial. The COPPS Trial: COlchicine for the Prevention of Postpericardiotomy Syndrome

Azienda Sanitaria Locale 3, Torino8 个研究点 分布在 1 个国家目标入组 360 人开始时间: 2005年6月1日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
360
试验地点
8
主要终点
Postpericardiotomy syndrome

研究概览

简要总结

The purpose of the study is to determine whether colchicine is safe and effective in the prevention of the postpericardiotomy syndrome.

详细描述

The postpericardiotomy syndrome is a frequent complication after cardiac surgery affecting from 20 to 40% of patients. The etiology of this complication is a subject of debate. It is commonly believed to be an autoimmune response to pericardial and/or pleural bleeding or surgical trauma. Colchicine is safe and effective in the treatment and prevention of pericarditis and preliminary data have shown that it may be effective also in the primary prevention of the postpericardiotomy syndrome.

Comparisons: The study will compare the safety and efficacy of colchicine in the primary prevention of the postpericardiotomy syndrome in addition to optimal standard care.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients in the third day after a cardiac surgery operation
  • Age≥ 18 years
  • Informed consent

排除标准

  • All evaluated before the surgical operation:
  • Known severe liver disease and/or elevated transaminases >1.5 times the upper limit of normality
  • Serum creatinine >2.5 mg/dl
  • Serum creatine kinase (CK) over the upper limit of normality or known myopathy
  • Known gastrointestinal or blood disease
  • Pregnant or lactating women or women not protected by a contraception method
  • Known hypersensibility to colchicine
  • Treatment with colchicine at enrolment

结局指标

主要结局

Postpericardiotomy syndrome

时间窗: 12 months

次要结局

  • Disease-related hospitalization, cardiac tamponade, constrictive pericarditis and relapses

研究者

发起方
Azienda Sanitaria Locale 3, Torino
申办方类型
Other

研究点 (8)

Loading locations...

相似试验